PINTO ALEXIS (Chief Legal Officer) sold 3.0% of their position (691.00 shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $34.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/14/2022ACC: 0001725160-22-000034
Officer· Chief Legal Officer
Since Aug 2020
+54.20K
Net shares
Net buyer
$34.7K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
54.89K acquired · 691.00 disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+16.41K
Price / share
—
Trade value
—
% of position
251.4%
2/10/2022
6.53K→22.93K
Common Stock
Direct
Shares
−614.00
Price / share
$50.16
Trade value
$30.80K
% of position
2.7%
2/14/2022
22.93K→22.32K
Common Stock
Direct
Shares
−77.00
Price / share
$50.75
Trade value
$3.91K
% of position
0.3%
2/14/2022
22.32K→22.24K
Total
Net shares
+15.71K
Net value
-$34.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2022 | A · Award | +16.41K | — | — | 251.4% | 6.53K | 22.93K |
| Common Stock Direct | 2/14/2022 | S · Sale | −614.00 | $50.16 | $30.80K | 2.7% | 22.93K | 22.32K |
| Common Stock Direct | 2/14/2022 | S · Sale | −77.00 | $50.75 | $3.91K | 0.3% | 22.32K | 22.24K |
| Total | +15.71K | -$34.71K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
38.49K shares
Shares
+38.49K
Strike price
52.61
Held after
38.49K
Exercisable
—
2/10/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock38.49K shares | 2/10/2022 | A · Award | +38.49K | 52.61 | — | 38.49K |